Moneycontrol PRO
HomeNewsBusinessIPOShelter Pharma fails to touch issue price on debut, closes at Rs 41.96

Shelter Pharma fails to touch issue price on debut, closes at Rs 41.96

Shelter Pharma's trading volume on the listing day was 11.16 lakh shares.

August 23, 2023 / 19:24 IST
Shelter Pharma

Shelter Pharma, a herbal products maker, has raised Rs 16.03 crore via public issue.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shelter Pharma failed to surpass its issue price on listing day, August 23, despite the northward journey in equity markets. The stock closed the day with one-tenth of a percent loss.

The stock opened the session at Rs 39.97 on the BSE SME, down 4.83 percent compared to the issue price of Rs 42 and hit a day's low of Rs 37.98 (down 9.6 percent).

It showed some recovery in the last couple of hours of trade and climbed up to Rs 41.96, which is also a close price of the day, down 0.09 percent, but could not hit the IPO price.

The trading volume on the listing day was 11.16 lakh shares.

Also read: Ratnaveer Precision Engineering IPO opens on September 4

The herbal products maker has raised Rs 16.03 crore via public issue, which comprised only fresh issue. The funds, excluding issue expenses, will be utilised for working capital requirements and general corporate purposes.

It was a fixed-price issue. The offer price was Rs 42 per share.

Incorporated in 2007, Shelter Pharma manufactures herbal products in human pharma as well as the veterinary space.

Click Here To Read All IPO News

Sunil Shankar Matkar
first published: Aug 23, 2023 07:24 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347